Date: 20 март 2020 21:51:39
Subject: Discover COVID-19 Research on ChemRxiv
In light of the current outbreak of a novel coronavirus (2019–nCoV), ChemRxiv would like to share this collection of preprints* on COVID-19. Chemistry has a key role to play in understanding everything from viral structure to pathogenesis, isolation of vaccines and therapies, as well as in the development of materials and techniques used by basic researchers, virologists, and clinicians.
ChemRxiv is openly accessible, with no subscription fees for readers and no submission charges for authors. We encourage you to read and share this collection with colleagues and also invite you to share your research with a global community of scientists by posting your COVID-19 research on ChemRxiv.
Read a Selection of COVID-19 Research:
A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry
Mohamed El-Tholoth, Haim H. Bau, and Jinzhao Song
Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface
Micholas Smith and Jeremy C. Smith
Homology Models of the Papain-Like Protease PLpro from Coronavirus 2019-nCoV
COVID-19 Disease: ORF8 and Surface Glycoprotein Inhibit Heme Metabolism by Binding to Porphyrin
Wenzhong Liu and Hualan Li
Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations
Junjie Zou, Jian Yin, Lei Fang, Mingjun Yang, Tianyuan Wang, Weikun Wu, Peiyu Zhang
Virtual Screening of an FDA Approved Drugs Database on Two COVID-19 Coronavirus Proteins
Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates
Yu Wai Chen, Chin-Pang Yiu, and Kwok-Yin Wong
Homology Models of Coronavirus 2019-nCoV 3CLpro Protease
Molecular Docking Study of Novel COVID-19 Protease with Low Risk Terpenoides Compounds of Plants
*Please note that ChemRxiv preprints have not been peer-reviewed and as such should be read with additional scrutiny. In the event that these preprints have subsequently appeared in a peer-reviewed journal, a link denoting this will appear on the page.